載入...

Treatment of Rheumatoid Arthritis With Anti–Tumor Necrosis Factor or Tocilizumab Therapy as First Biologic Agent in a Global Comparative Observational Study

OBJECTIVE: To compare clinical effectiveness between tocilizumab and tumor necrosis factor inhibitors (TNFi) in patients with rheumatoid arthritis (RA) and inadequate response to conventional synthetic disease‐modifying antirheumatic drugs initiating biologic therapy. METHODS: Patients prescribed to...

全面介紹

Na minha lista:
書目詳細資料
發表在:Arthritis Care Res (Hoboken)
Main Authors: Choy, Ernest H., Bernasconi, Corrado, Aassi, Maher, Molina, Jose Fernando, Epis, Oscar Massimiliano
格式: Artigo
語言:Inglês
出版: John Wiley and Sons Inc. 2017
主題:
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC5656814/
https://ncbi.nlm.nih.gov/pubmed/28622454
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/acr.23303
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!